- Home
- AMLX vs BFS Comparison
AMLX vs BFS Comparison
Compare AMLX & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- BFS
- Stock Information
- Founded
- AMLX 2014
- BFS 1993
- Country
- AMLX United States
- BFS United States
- Employees
- AMLX N/A
- BFS N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- BFS Real Estate Investment Trusts
- Sector
- AMLX Health Care
- BFS Real Estate
- Exchange
- AMLX Nasdaq
- BFS Nasdaq
- Market Cap
- AMLX 749.9M
- BFS 770.5M
- IPO Year
- AMLX 2022
- BFS 1993
- Fundamental
- Price
- AMLX $14.45
- BFS $31.21
- Analyst Decision
- AMLX Strong Buy
- BFS
- Analyst Count
- AMLX 7
- BFS 0
- Target Price
- AMLX $16.86
- BFS N/A
- AVG Volume (30 Days)
- AMLX 1.9M
- BFS 70.4K
- Earning Date
- AMLX 11-06-2025
- BFS 11-05-2025
- Dividend Yield
- AMLX N/A
- BFS 7.59%
- EPS Growth
- AMLX N/A
- BFS N/A
- EPS
- AMLX N/A
- BFS 1.32
- Revenue
- AMLX N/A
- BFS $277,902,000.00
- Revenue This Year
- AMLX N/A
- BFS $6.92
- Revenue Next Year
- AMLX N/A
- BFS $4.90
- P/E Ratio
- AMLX N/A
- BFS $23.56
- Revenue Growth
- AMLX N/A
- BFS 5.23
- 52 Week Low
- AMLX $2.60
- BFS $29.76
- 52 Week High
- AMLX $16.96
- BFS $42.39
- Technical
- Relative Strength Index (RSI)
- AMLX 55.78
- BFS 50.45
- Support Level
- AMLX $13.88
- BFS $29.76
- Resistance Level
- AMLX $16.96
- BFS $30.75
- Average True Range (ATR)
- AMLX 0.99
- BFS 0.50
- MACD
- AMLX -0.20
- BFS 0.13
- Stochastic Oscillator
- AMLX 33.77
- BFS 72.14
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.